200 related articles for article (PubMed ID: 22916154)
41. Tumorigenesis promotes Mdm4-S overexpression.
Pant V; Larsson CA; Aryal N; Xiong S; You MJ; Quintas-Cardama A; Lozano G
Oncotarget; 2017 Apr; 8(16):25837-25847. PubMed ID: 28460439
[TBL] [Abstract][Full Text] [Related]
42. Rare MDM4 gene amplification in colorectal cancer: The principle of a mutually exclusive relationship between MDM alteration and TP53 inactivation is not applicable.
Suda T; Yoshihara M; Nakamura Y; Sekiguchi H; Godai TI; Sugano N; Tsuchida K; Shiozawa M; Sakuma Y; Tsuchiya E; Kameda Y; Akaike M; Matsukuma S; Miyagi Y
Oncol Rep; 2011 Jul; 26(1):49-54. PubMed ID: 21503588
[TBL] [Abstract][Full Text] [Related]
43. Genetic association of single nucleotide polymorphisms in P53 pathway with gastric cancer risk in a Chinese Han population.
Wu GC; Zhang ZT
Med Oncol; 2015 Jan; 32(1):401. PubMed ID: 25479941
[TBL] [Abstract][Full Text] [Related]
44. MDM4 enhances p53 stability by promoting an active conformation of the protein upon DNA damage.
Di Conza G; Mancini F; Buttarelli M; Pontecorvi A; Trimarchi F; Moretti F
Cell Cycle; 2012 Feb; 11(4):749-60. PubMed ID: 22374672
[TBL] [Abstract][Full Text] [Related]
45. The long and the short of it: the MDM4 tail so far.
Haupt S; Mejía-Hernández JO; Vijayakumaran R; Keam SP; Haupt Y
J Mol Cell Biol; 2019 Mar; 11(3):231-244. PubMed ID: 30689920
[TBL] [Abstract][Full Text] [Related]
46. MDM2 and MDM4: p53 regulators as targets in anticancer therapy.
Toledo F; Wahl GM
Int J Biochem Cell Biol; 2007; 39(7-8):1476-82. PubMed ID: 17499002
[TBL] [Abstract][Full Text] [Related]
47. Genomic differences between retinoma and retinoblastoma.
Sampieri K; Mencarelli MA; Epistolato MC; Toti P; Lazzi S; Bruttini M; De Francesco S; Longo I; Meloni I; Mari F; Acquaviva A; Hadjistilianou T; Renieri A; Ariani F
Acta Oncol; 2008; 47(8):1483-92. PubMed ID: 18785023
[TBL] [Abstract][Full Text] [Related]
48. Genomic aberrations of MDM2, MDM4, FGFR1 and FGFR3 are associated with poor outcome in patients with salivary gland cancer.
Ach T; Schwarz-Furlan S; Ach S; Agaimy A; Gerken M; Rohrmeier C; Zenk J; Iro H; Brockhoff G; Ettl T
J Oral Pathol Med; 2016 Aug; 45(7):500-9. PubMed ID: 26661925
[TBL] [Abstract][Full Text] [Related]
49. The evolution of MDM2 family genes.
Momand J; Villegas A; Belyi VA
Gene; 2011 Oct; 486(1-2):23-30. PubMed ID: 21762762
[TBL] [Abstract][Full Text] [Related]
50. Mdm2 and Mdm4 loss regulates distinct p53 activities.
Barboza JA; Iwakuma T; Terzian T; El-Naggar AK; Lozano G
Mol Cancer Res; 2008 Jun; 6(6):947-54. PubMed ID: 18567799
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of Retinoblastoma Cell Growth by CEP1347 Through Activation of the P53 Pathway.
Togashi K; Okada M; Suzuki S; Sanomachi T; Seino S; Yamamoto M; Yamashita H; Kitanaka C
Anticancer Res; 2020 Sep; 40(9):4961-4968. PubMed ID: 32878784
[TBL] [Abstract][Full Text] [Related]
52. MDM4 genetic variants and risk of gastric cancer in an Eastern Chinese population.
Wang MY; Jia M; He J; Zhou F; Qiu LX; Sun MH; Yang YJ; Wang JC; Jin L; Wang YN; Wei QY
Oncotarget; 2017 Mar; 8(12):19547-19555. PubMed ID: 28099948
[TBL] [Abstract][Full Text] [Related]
53. Dysregulation of Mdm2 and Mdm4 alternative splicing underlies motor neuron death in spinal muscular atrophy.
Van Alstyne M; Simon CM; Sardi SP; Shihabuddin LS; Mentis GZ; Pellizzoni L
Genes Dev; 2018 Aug; 32(15-16):1045-1059. PubMed ID: 30012555
[TBL] [Abstract][Full Text] [Related]
54. Regulation of p14ARF expression by miR-24: a potential mechanism compromising the p53 response during retinoblastoma development.
To KH; Pajovic S; Gallie BL; Thériault BL
BMC Cancer; 2012 Feb; 12():69. PubMed ID: 22336108
[TBL] [Abstract][Full Text] [Related]
55. Identification and expression of a novel MDM4 splice variant in human glioma.
Wang X; Sheng P; Guo X; Wang J; Hou L; Hu G; Luo C; Dong Y; Lu Y
Brain Res; 2013 Nov; 1537():260-6. PubMed ID: 23994448
[TBL] [Abstract][Full Text] [Related]
56. Alteration of the MDM2-p73-P14ARF pathway related to tumour progression during urinary bladder carcinogenesis.
Schlott T; Quentin T; Korabiowska M; Budd B; Kunze E
Int J Mol Med; 2004 Nov; 14(5):825-36. PubMed ID: 15492852
[TBL] [Abstract][Full Text] [Related]
57. Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo.
Francoz S; Froment P; Bogaerts S; De Clercq S; Maetens M; Doumont G; Bellefroid E; Marine JC
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3232-7. PubMed ID: 16492744
[TBL] [Abstract][Full Text] [Related]
58. Expression of alternatively spliced mdm2 transcripts correlates with stabilized wild-type p53 protein in human glioblastoma cells.
Kraus A; Neff F; Behn M; Schuermann M; Muenkel K; Schlegel J
Int J Cancer; 1999 Mar; 80(6):930-4. PubMed ID: 10074928
[TBL] [Abstract][Full Text] [Related]
59. MDM2 and MDM4 Are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors.
Howard TP; Arnoff TE; Song MR; Giacomelli AO; Wang X; Hong AL; Dharia NV; Wang S; Vazquez F; Pham MT; Morgan AM; Wachter F; Bird GH; Kugener G; Oberlick EM; Rees MG; Tiv HL; Hwang JH; Walsh KH; Cook A; Krill-Burger JM; Tsherniak A; Gokhale PC; Park PJ; Stegmaier K; Walensky LD; Hahn WC; Roberts CWM
Cancer Res; 2019 May; 79(9):2404-2414. PubMed ID: 30755442
[TBL] [Abstract][Full Text] [Related]
60. Synergistic regulation of p53 by Mdm2 and Mdm4 is critical in cardiac endocardial cushion morphogenesis during heart development.
Zhang Q; He X; Chen L; Zhang C; Gao X; Yang Z; Liu G
J Pathol; 2012 Nov; 228(3):416-28. PubMed ID: 22821713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]